Patients need proof, not presumption
The regenerative medicine movement is finally finding its stride and emerging at a healthy pace, along with growing systems of support and accountability. Because of this progress, patients need now more than ever to be able to depend upon neutral interpretations of information. In this editorial, Doug Oliver responds to Leigh Turner’s recent interview and perspective on how, why and when cell therapy providers allegedly exploit ClinicalTrials.gov.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>